{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:38:21Z","timestamp":1761154701759},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1982,1,1]],"date-time":"1982-01-01T00:00:00Z","timestamp":378691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1982]]},"DOI":"10.1007\/bf00548398","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T06:01:28Z","timestamp":1100844088000},"page":"309-314","source":"Crossref","is-referenced-by-count":29,"title":["Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol"],"prefix":"10.1007","volume":"22","author":[{"given":"B.","family":"Brantmark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"W\ufffdhlin-Boll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Melander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/01.STR.8.3.301","volume":"8","author":"WS Fields","year":"1977","unstructured":"Fields WS, Lemak NA, Frankowski RF, Hardy RJ (1977) Controlled trial of aspirin in cerebral ischemia. Stroke 8: 301?314","journal-title":"Stroke"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJM197807132990201","volume":"299","author":"HJM Barnett","year":"1978","unstructured":"Barnett HJM et al. (Candadian Cooperative Study Group) (1978) A Randomized trial of aspirin and sulfonpyrazone in threatened stroke. N Engl J Med 299: 53?59","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM197909133011103","volume":"301","author":"HR Harter","year":"1979","unstructured":"Harter HR, Burch JW, Majerus PW, Stanford N, Delmez JA, Anderson CB, Weerts CA (1979) Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med 301: 577?579","journal-title":"N Engl J Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.STR.11.1.4","volume":"11","author":"JE Olsson","year":"1980","unstructured":"Olsson JE, Brechter C, B\u00e4cklund H, Krook H, M\u00fcller R, Nitelius E, Olsson O, Tornberg A (1980) Anticoagulant vs antiplatelet therapy as prophylactic againts cerebral infarction in transient ischemic attacks. Stroke 11: 1?9","journal-title":"Stroke"},{"key":"CR5","first-page":"325","volume":"9","author":"K Breddin","year":"1980","unstructured":"Breddin K, Loew D, Lechner K, \u00dcberla K, Walter (1980) Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. Haemostasis 9: 325?344","journal-title":"Haemostasis"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.me.31.020180.000513","volume":"31","author":"JF Mustard","year":"1980","unstructured":"Mustard JF, Kinlough-Rathbone RL, Packham MA (1980) Prostaglandins and platelets. Annu Rev Med 31: 89?96","journal-title":"Annu Rev Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","volume":"231","author":"JR Vane","year":"1971","unstructured":"Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature, New Biol 231: 232?240","journal-title":"Nature, New Biol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.2042-7158.1978.tb13171.x","volume":"30","author":"BB Vargaftig","year":"1978","unstructured":"Vargaftig BB (1978) Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the rat. J Pharm Pharmacol 30: 101?106","journal-title":"J Pharm Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(81)91371-4","volume":"II","author":"B Brantmark","year":"1981","unstructured":"Brantmark B, Hedner U, Melander A, W\u00e5hlin-Boll E (1981) Salicylate inhibition of antiplatelet effect of aspirin. Lancet II: 1349","journal-title":"Lancet"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0014-2999(78)90355-2","volume":"50","author":"BB Vargaftig","year":"1978","unstructured":"Vargaftig BB (1978) The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines. Eur J Pharmacol 50: 231?241","journal-title":"Eur J Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/03602537909046431","volume":"9","author":"G Levy","year":"1979","unstructured":"Levy G (1979) Pharmacokinetics of salicylate in man. Drug Metab Rev 9: 3?19","journal-title":"Drug Metab Rev"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/01.CIR.62.3.449","volume":"62","author":"The Persantine-Aspirin Reinfarction Study Research Group","year":"1980","unstructured":"The Persantine-Aspirin Reinfarction Study Research Group (1980) Persantine and aspirin in coronary heart disease. Circulation 62: 449?461","journal-title":"Circulation"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF00615408","volume":"20","author":"E W\u00e5hlin-Boll","year":"1981","unstructured":"W\u00e5hlin-Boll E, Brantmark B, Hanson A, Melander A, Nilsson C (1981) High-pressure liquid chromatographic determination of acetylsalicylic acid, salicylic acid, diflunisal, indomethacin, indoprofen and indobufen. Eur J Clin Pharmacol 20: 375?378","journal-title":"Eur J Clin Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00611905","volume":"14","author":"C Bogentoft","year":"1978","unstructured":"Bogentoft C, Carlsson I, Ekenved G, Magnusson A (1978) Influence of food on the absorption of acetylsalicylic acid from enteric coated-dosage forms. Eur J Clin Pharmacol 14: 351?355","journal-title":"Eur J Clin Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.STR.11.1.9","volume":"11","author":"M Ali","year":"1980","unstructured":"Ali M, McDonald JWD, Thiessen JJ, Coates PE (1980) Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin. Stroke 11: 9?13","journal-title":"Stroke"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00548398.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00548398\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00548398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T19:32:06Z","timestamp":1554406326000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00548398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1982]]}},"alternative-id":["BF00548398"],"URL":"https:\/\/doi.org\/10.1007\/bf00548398","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982]]}}}